Assistência farmacêutica nos centros de infusão de medicamentos injetáveis oncológicos e imunobiológicos para pacientes pediátricos: uma revisão de escopo

Abstract

Oncological and immunobiological medication infusion centers represent a complex environment where the integration of different disciplines is essential to ensure the efficacy and safety of treatments, especially for pediatric patients. The patient-centered approach has been increasingly valued over the traditional disease-focused approach, with pharmacists playing a fundamental role in this context. This study aimed to map the role of pharmacists in multidisciplinary teams caring for pediatric patients in oncological and immunobiological medication infusion centers. The methodology adopted was a scoping review, encompassing a wide range of evidence sources, including primary and secondary studies as well as official documents. Searches were conducted in the electronic databases LILACS, Medline via PubMed, Embase, Cochrane, and Scopus without restrictions on language or publication date. Eligibility criteria were applied in a two-stage screening process, with discrepancies resolved through arbitration by a third reviewer. Data were independently extracted and synthesized using descriptive statistics, presented through tables and charts as appropriate. A total of 963 studies were identified, with 190 references excluded as duplicates before the selection process. After screening, 41 studies were retrieved for full reading and compliance analysis with eligibility criteria. In the end, 10 were excluded for not meeting eligibility criteria, and 25 were selected for this review. This study highlighted the role of clinical pharmacists as key members of multidisciplinary teams in pediatric oncological and immunobiological medication infusion centers. Their interventions showed a significant impact in reducing medication errors, improving patient safety, and optimizing drug therapy.